Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 USD | +2.94% | -4.37% | +209.73% |
05-09 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
05-09 | Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+209.73% | 321M | |
+37.74% | 723B | |
+34.26% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+17.06% | 244B | |
+9.87% | 208B | |
-4.38% | 205B | |
+2.81% | 168B |
- Stock Market
- Equities
- NKTR Stock
- News Nektar Therapeutics
- Insider Trends: Selling By Insiders Lingers at Nektar Therapeutics